Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
Status:
Completed
Trial end date:
2019-06-13
Target enrollment:
Participant gender:
Summary
This trial consists of 3 parts: a pilot safety phase, a pivotal randomized controlled phase,
and an open-label extension phase. The open-label extension phase only will be described in
this record. All participants will receive GWP42003-P.